(Circulation. 2000;101:264.)
© 2000 American Heart Association, Inc.
Clinical Investigation and Reports |
Association of Blood Pressure With Fibrinolytic Potential in the Framingham Offspring Population
From Framingham Heart Study, National Heart, Lung, and Blood Institute, Framingham, Mass (K.A.P., M.G.L., J.C.E., P.A.S., P.W.F.W., D.L.); Institute for the Prevention of Cardiovascular Disease, Cardiovascular Division, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass (K.A.P., G.H.T., I.L., M.A.M., J.E.M.); National Heart, Lung and Blood Institute, Bethesda, Md (P.W.F.W., D.L.); and Department of Mathematics, Boston University, Boston, Mass (M.G.L., J.C.E., P.A.S., R.B.D.).
Correspondence to Daniel Levy, MD, Framingham Heart Study, Five Thurber Street, Framingham, MA 01702.
Background—Hypertension is an established risk factor for acute coronary events. Because fibrinolytic and hemostatic factors are also associated with cardiovascular disease, we examined the relations of systolic and diastolic blood pressures (SBP and DBP) to levels of plasminogen activator inhibitor antigen, tissue plasminogen activator antigen, fibrinogen, factor VII, von Willebrand factor, fibrinogen, and plasma viscosity in subjects of the Framingham Offspring Study.
Methods and Results—We studied 1193 men and 1459 women after the exclusion of subjects with known cardiovascular disease and those receiving anticoagulant or antihypertensive therapy. Linear regression models were used to evaluate SBP and DBP as predictors of fibrinolytic and hemostatic factor levels in separate sex models, with adjustment for age, body mass index, smoking, diabetes, total cholesterol, HDL, triglycerides, alcohol intake, and estrogen use (in women). In both sexes, levels of plasminogen activator inhibitor and tissue plasminogen activator antigen were positively related to SBP and DBP (P<0.001). Plasma viscosity was positively related to SBP (P=0.008) and DBP (P=0.001) in women only. There was no association between SBP or DBP and fibrinogen, factor VII, or von Willebrand factor in either sex.
Conclusions—These data suggest that impaired fibrinolysis may play an important role in the pathogenesis of cardiovascular disease in hypertensive patients.
Key Words: hypertension • fibrinolysis • cardiovascular diseases
This article has been cited by other articles:
 |
|
 |
|
  C. Giannarelli, A. Virdis, F. De Negri, E. Duranti, A. Magagna, L. Ghiadoni, A. Salvetti, and S. Taddei Tissue-Type Plasminogen Activator Release in Healthy Subjects and Hypertensive Patients: Relationship With {beta}-Adrenergic Receptors and the Nitric Oxide Pathway Hypertension, August 1, 2008; 52(2): 314 - 321. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Lieb, M. J. Pencina, T. J. Wang, M. G. Larson, K. J. Lanier, E. J. Benjamin, D. Levy, G. H. Tofler, J. B. Meigs, C. Newton-Cheh, et al. Association of Parental Hypertension With Concentrations of Select Biomarkers in Nonhypertensive Offspring Hypertension, August 1, 2008; 52(2): 381 - 386. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. F. Panoulas, G. S. Metsios, A. V. Pace, H. John, G. J. Treharne, M. J. Banks, and G. D. Kitas Hypertension in rheumatoid arthritis Rheumatology, May 29, 2008; (2008) ken159v2. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. Wang, P. Gona, M. G. Larson, D. Levy, E. J. Benjamin, G. H. Tofler, P. F. Jacques, J. B. Meigs, N. Rifai, J. Selhub, et al. Multiple Biomarkers and the Risk of Incident Hypertension Hypertension, March 1, 2007; 49(3): 432 - 438. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Shankar, J. J. Wang, E. Rochtchina, and P. Mitchell Positive Association Between Plasma Fibrinogen Level and Incident Hypertension Among Men: Population-Based Cohort Study Hypertension, December 1, 2006; 48(6): 1043 - 1049. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kathiresan, S. B. Gabriel, Q. Yang, A. L. Lochner, M. G. Larson, D. Levy, G. H. Tofler, J. N. Hirschhorn, and C. J. O'Donnell Comprehensive Survey of Common Genetic Variation at the Plasminogen Activator Inhibitor-1 Locus and Relations to Circulating Plasminogen Activator Inhibitor-1 Levels Circulation, September 20, 2005; 112(12): 1728 - 1735. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Arikan and S. Sen Endothelial Damage and Hemostatic Markers in Patients with Uncomplicated Mild-to-Moderate Hypertension and Relationship with Risk Factors Clinical and Applied Thrombosis/Hemostasis, April 1, 2005; 11(2): 147 - 159. [Abstract] [PDF]
|
|
|
|
 |
|
 R. Rossi, E. Chiurlia, A. Nuzzo, E. Cioni, G. Origliani, and M. G. Modena Flow-mediated vasodilation and the risk of developing hypertension in healthy postmenopausal women J. Am. Coll. Cardiol., October 19, 2004; 44(8): 1636 - 1640. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Hayashi, E. J. Boyko, D. L. Leonetti, M. J. McNeely, L. Newell-Morris, S. E. Kahn, and W. Y. Fujimoto Visceral Adiposity Is an Independent Predictor of Incident Hypertension in Japanese Americans Ann Intern Med, June 15, 2004; 140(12): 992 - 1000. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. D. Sesso, J. E. Buring, N. Rifai, G. J. Blake, J. M. Gaziano, and P. M. Ridker C-Reactive Protein and the Risk of Developing Hypertension JAMA, December 10, 2003; 290(22): 2945 - 2951. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Hayashi, E. J. Boyko, D. L. Leonetti, M. J. McNeely, L. Newell-Morris, S. E. Kahn, and W. Y. Fujimoto Visceral Adiposity and the Prevalence of Hypertension in Japanese Americans Circulation, October 7, 2003; 108(14): 1718 - 1723. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Hognert, B. Ghanoum, H. Gustafsson, I. Milsom, and K. Manhem Acute Effects of Transdermal 17{beta}-Estradiol on Hemostatic Variables after 24-hour Treatment Clinical and Applied Thrombosis/Hemostasis, July 1, 2002; 8(3): 239 - 243. [Abstract] [PDF]
|
|
|
|
|
|
C. G.C. Spencer, D. Gurney, A. D. Blann, D. G. Beevers, and G. Y.H. Lip Von Willebrand Factor, Soluble P-Selectin, and Target Organ Damage in Hypertension: A Substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) Hypertension, July 1, 2002; 40(1): 61 - 66. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. GLICK Screening for traditional risk factors for cardiovascular disease: A review for oral health care providers J Am Dent Assoc, March 1, 2002; 133(3): 291 - 300. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. U. Chae, R. T. Lee, N. Rifai, and P. M. Ridker Blood Pressure and Inflammation in Apparently Healthy Men Hypertension, September 1, 2001; 38(3): 399 - 403. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. J. Brown, L. J. Murphey, N. Srikuma, N. Koschachuhanan, G. H. Williams, and D. E. Vaughan Interactive Effect of PAI-1 4G/5G Genotype and Salt Intake on PAI-1 Antigen Arterioscler. Thromb. Vasc. Biol., June 1, 2001; 21(6): 1071 - 1077. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Y. H. Lip Target Organ Damage and the Prothrombotic State in Hypertension Hypertension, December 1, 2000; 36(6): 975 - 977. [Full Text] [PDF]
|
|
|
|
|
|
L. A. Sechi, L. Zingaro, C. Catena, D. Casaccio, and S. De Marchi Relationship of Fibrinogen Levels and Hemostatic Abnormalities With Organ Damage in Hypertension Hypertension, December 1, 2000; 36(6): 978 - 985. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-C. Chen, J. L. Bouchie, A. S. Perez, A. C. Clermont, S. Izumo, J. Hampe, and E. P. Feener Role of the Angiotensin AT1 Receptor in Rat Aortic and Cardiac PAI-1 Gene Expression Arterioscler. Thromb. Vasc. Biol., October 1, 2000; 20(10): 2297 - 2302. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Hypertension Associated with Prothrombotic State Journal Watch (General), January 28, 2000; 2000(128): 8 - 8. [Full Text]
|
|
|
|
|
|
G. Y. H. Lip and A. D. Blann Does Hypertension Confer a Prothrombotic State? : Virchow’s Triad Revisited Circulation, January 25, 2000; 101(3): 218 - 220. [Full Text] [PDF]
|
|